Australia's MedAdvisor drops to 7-week low on downbeat HY outlook
** MedAdvisor MDR.AX drops as much as 24.1% to A$0.205,
lowest since Oct. 31
** Medical software co sees group's H1 FY25 rev 25%-30%
below the record $75.5 mln in 1H FY24 on lower-than-expected
vaccination rates
** Stock posts biggest intraday pct fall since Oct. 31
** Around 1.1 mln shares traded vs the 30-day avg of 614,572
** Stock rises 25.6% this year, as of last close
(Reporting by Nichiket Sunil in Bengaluru)
((Nichiket.Sunil@thomsonreuters.com))
Recent news on Adheris Health
See all newsBrief: Adheris Health Posts Q3 Operating Revenue Of A$5.4M
Brief: Adheris Health Posts HY Profit From Ordinary Activities After Tax Attributable A$7.3 Million
Brief: Adheris Health Expects 30% Total Operating Cost Savings Over Two Years
Brief: Adheris Health Posts Q2 Operating Revenue A$13.7 Million
Brief: Adheris Health Says A$6.1M Holdback Consideration Received